In-vitro effects of antimicrobial agents on Pseudomonas aeruginosa biofilm formation
- PMID: 7829408
- DOI: 10.1093/jac/34.3.331
In-vitro effects of antimicrobial agents on Pseudomonas aeruginosa biofilm formation
Abstract
The in-vitro effects of ten antimicrobial agents on the biofilm formation of Pseudomonas aeruginosa were investigated. The production of alginic acid by mucoid P. aeruginosa cells cultured in agar media with sub-MICs of antimicrobial agents was quantified by high-performance liquid chromatography. Alginic acid production was inhibited by 1/4 MIC of minocycline (P < 0.002) and tobramycin (P < 0.02), and by 1/256-1/1/64 MIC of macrolides (erythromycin, clarithromycin, roxithromycin, and rokitamycin) and clindamycin (P < 0.02), compared with drug-free controls. Piperacillin, ceftazidime, and ofloxacin did not inhibit alginic acid production. The production of exopolysaccharide by non-mucoid P. aeruginosa cells grown on silicone plates in sub-MICs of antimicrobial agents was determined by quantitative tryptophan assay. Exopolysaccharide production was inhibited by 1/16 MIC of macrolides and clindamycin, but not by other antimicrobial agents. Electron microscopy showed that biofilm formation by mucoid and non-mucoid type P. aeruginosa strains was inhibited by sub-MICs of erythromycin and correlated with the in-vitro production of alginic acid and exopolysaccharide. These results suggest that sub-MICs of macrolides and clindamycin suppress biofilm formation by P. aeruginosa and that intractable chronic respiratory tract infections due to P. aeruginosa might be prevented.
Similar articles
-
The influence of azithromycin on the biofilm formation of Pseudomonas aeruginosa in vitro.Chemotherapy. 1996 May-Jun;42(3):186-91. doi: 10.1159/000239440. Chemotherapy. 1996. PMID: 8983885
-
Sub-minimum inhibitory concentrations of ceftazidime inhibit Pseudomonas aeruginosa biofilm formation.J Infect Chemother. 2018 Jun;24(6):428-433. doi: 10.1016/j.jiac.2018.01.007. Epub 2018 Feb 12. J Infect Chemother. 2018. PMID: 29449129
-
Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response.J Infect Chemother. 2000 Mar;6(1):1-7. doi: 10.1007/s101560050042. J Infect Chemother. 2000. PMID: 11810524
-
Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa.Chest. 2004 Feb;125(2 Suppl):62S-69S; quiz 69S. doi: 10.1378/chest.125.2_suppl.62s. Chest. 2004. PMID: 14872002 Review.
-
An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal.FEMS Immunol Med Microbiol. 2010 Aug;59(3):253-68. doi: 10.1111/j.1574-695X.2010.00690.x. Epub 2010 Apr 23. FEMS Immunol Med Microbiol. 2010. PMID: 20497222 Review.
Cited by
-
Spiramycin Disarms Pseudomonas aeruginosa without Inhibiting Growth.Antibiotics (Basel). 2023 Mar 2;12(3):499. doi: 10.3390/antibiotics12030499. Antibiotics (Basel). 2023. PMID: 36978366 Free PMC article.
-
Rearrangement of a large novel Pseudomonas aeruginosa gene island in strains isolated from a patient developing ventilator-associated pneumonia.J Clin Microbiol. 2014 Jul;52(7):2430-8. doi: 10.1128/JCM.01626-13. Epub 2014 Apr 30. J Clin Microbiol. 2014. PMID: 24789195 Free PMC article.
-
Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilm.BMC Microbiol. 2012 Sep 8;12:196. doi: 10.1186/1471-2180-12-196. BMC Microbiol. 2012. PMID: 22958421 Free PMC article.
-
Comparison of methods to test antibiotic combinations against heterogeneous populations of multiresistant Pseudomonas aeruginosa from patients with acute infective exacerbations in cystic fibrosis.Antimicrob Agents Chemother. 2009 Nov;53(11):4809-15. doi: 10.1128/AAC.00269-09. Epub 2009 Aug 24. Antimicrob Agents Chemother. 2009. PMID: 19704123 Free PMC article.
-
Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.Drugs. 2003;63(22):2501-20. doi: 10.2165/00003495-200363220-00015. Drugs. 2003. PMID: 14609360 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical